The phosphatase FIG4 regulates the concentration of phosphatidylinositol 3,5-diphosphate (PI3,5P 2 ), a molecule critical for endosomal/ lysosomal membrane trafficking and neuron function. We investigated Fig4 expression in the developing CNS of mice and rats using Western blot, real-time polymerase chain reaction, and morphological techniques in situ and in vitro and after spinal cord injury. Fig4 was expressed at a high levels throughout development in myelinating cells, particularly Schwann cells, and dorsal root ganglia sensory neurons. Fig4 protein and mRNA in CNS neurons were markedly diminished in adult versus embryonal animals. Spinal cord hemisection induced upregulation of Fig4 in adult spinal cord tissues that was associated with accumulation of lysosomes in neurons and glia. This accumulation appeared similar to the abnormal lysosomal storage observed in dorsal root ganglia of young fig4-null mice. The results suggest that Fig4 is involved in normal neural development and the maintenance of peripheral nervous system myelin. We speculate that adequate levels of Fig4 may be required to prevent neurons and glia from excessive lysosomal accumulation after injury and in neurodegeneration.
INTRODUCTION
FIG4 is a phosphatase that interacts with phosphatidylinositol-5-phosphate (PI5P) kinase Fab1 in yeast or PIKfyve in mammalian cells. Fig4/PIKfyve and the kinase activators vac7 and 14 in yeast or arPIKfyve in mammalian cells form a protein complex that regulates the production of phophatidylinositol-3,5-diphosphate (PI3,5P 2 ). Loss of function of Fig4 reduces PI3,5P 2 levels presumably caused by disassembling this protein complex (1, 2) . Phosphoinositides, along with their interacting proteins, often coat intracellular organelle membranes, thereby regulating their membrane trafficking. The PI3,5P 2 is one type of phosphoinositides that appears to be particularly important for the endosome-lysosome system (3Y5).
Fig4/PI3,5P 2 signaling appears to be essential for cell survival in the nervous system. Loss of function of FIG4 in patients with Charcot-Marie-Tooth type 4J (CMT4J) and in pale tremor (plt) mice reduces PI3,5P 2 levels by approximately 71% and in association with severe neuronal degeneration (4Y6). Similarly, vac14 (or arPIKfyve)-knockout mice show a decrease of PI3,5P 2 level by approximately 50% and die in the perinatal period with profound neuronal degeneration (7, 8) . Despite these major functional effects, the localization of Fig4 in the nervous system has not been well characterized to date.
We systematically examined transcriptional and translational expression of Fig4 in the developing and mature nervous system in rodents. Localization of Fig4 protein and mRNA was mapped at the light microscopic and ultrastructural levels. Our results show that whereas Fig4 declines from the embryonic stage to adulthood, Fig4 levels remain high in myelinating cells and dorsal root ganglion (DRG) sensory neurons. These findings are interpreted in light of functional data derived from the present study as well as from our previously published studies in mice and humans with FIG4 deficiency (4, 5, 9) .
MATERIALS AND METHODS

Animals
C57BL6J background mice were purchased from Jackson Laboratory (n = 40 wild-type, 21 females + 19 pups, aged postnatal day 1 [P1]YP56). Sprague-Dawley rats were purchased from Charles River Laboratories International Inc. (11 wildtype females, È200 g; 19 males/females aged P1YP30; embryonic day 18 (E18) embryos from 2 pregnant females). Rodents were overdosed using pentobarbital (50 mg/kg intraperitoneally for rats and 1.5 mg/10 g intraperitoneally for mice) before tissue harvesting. The experiments were performed according to international ethics guidelines. The animal investigational committees of all institutions approved the use of animals for this study.
Semithin Sectioning, Transmission Electron Microscopy, and Immunoelectron Microscopy
The animals were transcardially perfused with 4% paraformaldehyde and 3.5% glutaraldehyde. The brain, spinal cord, and sciatic nerves were dissected and postfixed for 24 hours. Tissues were osmicated for 1.5 hours, dehydrated, and embedded in Epon. Tissue blocks were sectioned at 1-Km thickness and stained with methylene blue for light microscopic examination. The blocks were trimmed and cut into ultrathin sections for electron microscopy (EM) examination (Zeiss EM900 or FEI TECNAI-G 2 SPIRIT). For quantification of high electron-dense organelles, EM images were imported into ImagePro Plus software. Neurons and glia with or without the electron-dense organelles were counted manually to yield percentages of cells with high electrondense organelles. Definition and classification of these organelles are described in the Results section.
For immunoelectron microscopy (IEM), rats were transcardially perfused with 0.1 mol/L of sodium phosphate buffer containing 187.5 units/100 mL of heparin, followed by perfusion with 4% paraformaldehyde, 0.1% glutaraldehyde, and 15% saturated picric acid. Dissected spinal cords were postfixed in the same fixative for 2 to 3 hours. After 3 washes with PBS (10 minutes each), tissues were sectioned into 50-Km thickness and incubated in a cryoprotectant solution (0.1 mol/L of NaPB, 25% sucrose, and 10% glycerol) for 30 to 60 minutes until the sections sank. The sections were then frozen with liquid N 2 for several seconds and thawed in cryoprotectant at room temperature for 3 cycles. Sections were then blocked in 20% normal goat serum in TRIS buffer (pH 7.4). Sections were first incubated with primary antibodies in 2% normal goat serum solution at 4-C for 24 hours, followed by incubation with secondary antibodies overnight at 4-C, and postfixed in 1% glutaraldehyde for 10 minutes. The sections were silver enhanced with HQ silver Kit (NanoProbe 2012, Yaphank, NY), osmicated, dehydrated, and embedded into Epon. Epon blocks were sectioned and examined under EM (FEI TECNAI-G 2 SPIRIT).
Immunohistochemistry
Neural tissues were fixed in 4% paraformaldehyde for 12 hours. Tissue blocks were embedded into optimum cutting temperature (OCT) medium and kept at j80-C until used, or they were embedded in paraffin. The OCT blocks were sectioned in a cryostat (Leica) into 5-to 20-Km-thick sections. The slides were dried overnight, reacted with primary antibodies at 4-C overnight, and followed by incubation with secondary antibodies for 1.5 hours the next day. The stained slides were examined under a Leica fluorescent (DM6000B) or Zeiss confocal microscope (Zeiss LSM510). Antibodies used in the study are listed in the Table (10Y22). Experiments were done using a mouse anti-Fig4 monoclonal antibody that was produced from mice by NeuroMab (clone 75Y210). Antibody specificity was verified by performing Western blot on proteins extracted from wild-type and plt mouse brains. The plt mice have homozygous truncation mutations in the Fig4 gene that eliminates the expression of Fig4 protein (4) . The Western blot showed a specific band of Fig4 in wild-type brains but no corresponding band in plt brains (data not shown), indicating that the antibody is specific. Because the antibody was raised in mice, we performed studies on Fig4 localization in rat neural tissues.
Western Blot
Mouse brains, spinal cords, or sciatic nerves were chopped into small cubes and immediately frozen on dry ice. Samples were either processed immediately or stored at j80-C for future use. The samples were homogenized in ice-cold lysis buffer (radioimmunoprecipitation assay + protease inhibitor cocktail in 100:1 ratio) and incubated at 4-C for 30 minutes. Fig4 transcription level significantly declined at each age group from P7 to P56 (p G 0.05). *Significant for the comparison between P1 and P7 or P1 and P14, or P1 and P42 through P56; #Significant for the comparison between P7 and P14 or P7 and P42 through P56. The nonparametric Kruskal-Wallis test was used but does not assume normal distributions for the values. The nonparametric Wilcoxon rank-sum test was also used to compare ratios between 2 groups).
The supernatants were collected after the mixtures were centrifuged at 14,000 rpm for 8 minutes. The proteins were added into 2Â loading buffer (50 KL A-mercaptoethanol + 950 KL Laemmli buffer; no. 161Y0737, BioRad, Hercules, CA). The sample was heated for 10 minutes at 95-C, loaded into a gel (20 Kg of protein for each loading), and run at 100V for 75 to 105 minutes. The separated proteins were transferred to polyvinylidene fluoride membrane in the cold (4-C). The membranes were blocked with 5% dry nonfat milk in 1Â Tris buffered saline with 0.1% Tween-20, incubated with primary antibodies, followed by secondary antibodies. The staining was filmed and quantified by chemiluminescence.
Mixed DRG and Cortical Cultures, Immunocytochemistry, and Confocal Imaging
Rat DRGs were dissected from E18 embryos and transferred into 2 mL of Leibovitz L15 medium (Gibco, Grand Island, NY) by a sterile technique. The tissue was disaggregated by incubating in 0.25% trypsin for 30 minutes at 37-C, followed by trituration. After digestion, cells were washed 3 times with 10% fetal bovine serum in the medium, and the cell suspension was centrifuged at 1,000 rpm for 5 minutes. The cells were plated on laminin/poly-D-lysine (Sigma)Ycoated 4-well chambers in medium-A (Neurobasal-A medium containing 1% penicillinYstreptomycin solution, 2% B27, 2 mmol/L of L-glutamine and 50 ng/m of nerve growth factor). Subsequent medium changes were made every 3 days using medium-A. The cells were incubated at 37-C in a 5% CO 2 /95% air atmosphere.
At day 5 after plating, cells were fixed with 4% paraformaldehyde for 30 minutes, rinsed with 0.3% Triton X-100 in 0.1 mol/L of PBS 3Â for 10 minutes each, and blocked in 5% fish skin gelatin for 1 hour. Cells were incubated with primary antibodies overnight at 4-C, followed by incubation with secondary antibodies for 2 hours at room temperature. Slides were imaged under a confocal microscope (Zeiss LSM510). ). This abundance remained at P30 (BYB''). Strong immunoreactivity was found in spinal motor neurons at P1 (CYC''). This immunoreactivity became minimal at P30 (DYD''). Fig4 was detected in spinal white matter myelin (EYE'') and in the myelin of peripheral nerves and circled axons that were labeled by NFL immunoreactivity (F). (G) To examine Fig4 localization in the peripheral nerve myelin, we performed teased nerve fiber immunohistochemistry of the sciatic nerve. The nerve was not paraffin embedded and was taken from a yfp transgenic mouse that expresses yellow fluorescence proteins (YFPs) under a neuron-specific promoter to label axons. Fig4 was expressed in the myelin. (HYH'') Fig4 was found in oligodendrocyte cytoplasm, myelin, and its processes. Oligodendrocytes were labeled with antibody to aspartoacylase (ASPA). (IYI'') Fig4 immunoreactivity was not found in astrocytes immunolabeled for glial fibrillary acidic protein (GFAP). The mixed cell culture from the E18 brain was processed and studied similarly to DRG cultures.
Real-Time Polymerase Chain Reaction
The fresh spinal cords were ground in liquid N 2 . RNA was extracted in TRIzol. One microgram of RNA treated with RNase-free DNase was subjected to reverse transcriptional reaction with cDNA Cycle Kit (DRR037S, TaKaRa Bio Inc., Otsu, Japan). Fifty nanograms of cDNA was used for each real-time polymerase chain reaction (PCR) in TaKaRa SYBR Premix Ex Taq TM mixture (TaKaRa Bio Inc., DRR041S). Total reaction volume was 20 KL. The reaction took place in a Bio-Rad iCycler iQ5 PCR (BioRad). Comparison was based on normalization with the reading of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) transcription level. Reaction temperatures were 95-C for 30 seconds, 40 repeated cycles of 95-C for 5 seconds, and followed by 60-C for 31 seconds. The following primers were used: fig4, 5 ¶-AGACTGGCATCCTTCGA ACCAACT-3 ¶; 5 ¶-AGGTTAGGCTTGTCAATCAGCCCT-3 ¶; GA DPH, 5 ¶-GCCTTCCGTGTTCCTACCC-3 ¶, 5 ¶-TGAAGTCGCAG GAGACAACC-3 ¶.
In Situ Hybridization
Mice were transcardially perfused. Spinal cords were dissected from the T9 to T11 segment, postfixed in 4% paraformaldehyde for 2 to 4 hours, and saturated in 30% sucrose overnight at 4-C. The tissues were cryosectioned into 20-Km thickness and stored at j20-C; 1% diethylpyrocarbonate was added to these solutions or fixatives to prevent mRNA degradation. The sections were thawed, washed 3 times with in situ hybridization PBS, and incubated in blocking buffer (without probes) for 2 to 3 hours at 42-C to reduce nonspecific hybridization. Sections were reacted with 20 KL of hybridization solution containing fig4 probes overnight. Probes were digoxin-labeled Fig4-mRNA oligonucleotides (no. MK2887-m, Boster, Wuhan, China): 5 ¶-TGGGA CATGG CCAAG TACAC CAAGA GTAAG CTGTG-3 ¶. These sections were washed with 2Â SSC (NaCl 17.6 g, C6H5O7Na 3 8.8 g in 1,000 mL dH 2 O) for 15 minutes, 0.5Â SSC for 15 minutes, and 0.2Â SSC for 15 minutes. The sections were reacted with biotin for 60 minutes at 37-C, followed by reaction with SABC-Cy3 for 1 hour. After a brief staining with Hochest33342, the sections were coverslipped and examined under fluorescence microscopy.
Spinal Cord Injury
Rats and mice were anesthetized with pentobarbital sodium (35 mg/kg). Laminectomy was performed at T10, and the dura mater was cut. The spinal cord was hemitransected on the right side by iridectomy scissors. After surgery, the animals received an intramuscular injection of penicillin (50,000 U/kg per day) for 3 days. Bladder expression was performed twice a day until reflex bladder emptying was established. Sham-operated animals received laminectomy, but the hemisection was not applied to the spinal cord. We performed hemitransection at T10 of rat spinal cords (P6 to 8 weeks old) and harvested the cords immediately caudal to the T10 and at L1 at posttrauma days 7, 14, and 60. Corresponding segments of the spinal cord were also collected from rats with sham surgery. Rat tissues in the trauma experiments were embedded in OCT, sectioned, and stained by immunohistochemistry (IHC). Mouse spinal cords were hemitransected at T10. Tissues at T10 and L1 ipsilateral to the injury site were harvested 14 days after the surgery and examined by EM.
RESULTS
Fig4 Expression in Developing Neurons
To assess the overall expression of Fig4 in the nervous system, we performed Western blot on developing mouse neural tissues from E15 to P28. In both the brain and the spinal cord, Fig4 was expressed abundantly in E15 and P1 but decreased to minimal levels at P28 (Fig. 1A, B) . In contrast, the expression of Fig4 remains at a high level in sciatic nerves throughout development (Fig. 1C) .
To assess transcriptional changes during development, real-time PCR was used to quantify fig4 mRNA in the mouse spinal cords at P1, P7, P14, and P42 to P56. In line with Fig4 proteins, fig4 transcription was high at P1 and steadily decreased from P1 to P42 to P56. This reduction in each age group was significantly different from that in P1 (p G 0.05).
Fig4 mRNA level at P42YP56 dropped about 70% of that in the P1 mice (Fig. 1D) .
To localize the expression of Fig4, we performed IHC using the same anti-Fig4 antibody used in the Western blot ( Table) . We found that the Fig4 antibody produced better staining in paraffin-embedded sections with a brighter signal intensity than in OCT sections. Thus, all data on Fig4 localization in naive rats were collected from the paraffin sections.
Fig4 was highly expressed in embryonic tissues in all immature cells and was diffusely distributed in the spinal cord and brain. From E18 to P14, Fig4 was visualized in cortical neurons, neurons in spinal anterior horn, and sensory neurons of the DRG (Figs. 2AYC, H) . The expression in subcortical regions and brainstem was not assessed. By P30, Fig4 immunoreactivity was hardly detectable in the majority of CNS neurons (including spinal motor neurons, sensory/motor cortical neurons) (Fig. 2D) . It was still present in the perinuclear cytoplasm and myelin of oligodendrocytes and in DRG neurons (Figs. 2E, H) . The expression profiles in additional age groups are shown in Supplementary Figure 1 ; http://links.lww.com/NEN/A290.
Fig4 immunoreactivity was present in neuron nuclei, particularly in immature neurons, and was visible in many nuclei (arrow in Fig. 2A ) in DRG neurons at E18 to P14. By P30, most of the nuclei were devoid of Fig4. Fig4 in the nuclei of spinal cord neurons evolved similarly to that in the DRG neurons, but it disappeared by P14 in the nuclei of cortical neurons. It was not expressed in astrocytes labeled for glial fibrillary acidic protein (GFAP) at that age (Fig. 2I) .
Fig4 expression in peripheral nerves was examined in paraffin sections and using teased nerve fiber IHC. Fig4 was found in compact myelin (Figs. 2F, G) and was frequently detectable in the perinuclear cytoplasm of the myelinating Schwann cells but not in Schmidt-Lanterman incisures. In contrast, Fig4 staining was negligible in axons, nonmyelinating Schwann cells, or other cell types in sciatic nerves. This expression pattern did not change significantly throughout development, which is consistent with the persistent high level of Fig4 on the Western blot of the sciatic nerves (Fig. 1) .
To determine whether Fig4 expression is regulated transcriptionally in specific types of cells, we performed in situ hybridization with a nucleotide probe specific to the mRNA of fig4 (Fig. 3) . We found this technique to be sufficiently sensitive to detect fig4 mRNA even in mature mouse neurons (P42YP56). Thus, all in situ hybridization experiments were performed at this age and focused on the spinal cord. Fig4 mRNA was found in anterior horn neurons and where it FIGURE 6 . Mouse spinal cords were hemitransected at T10. Tissues at T10 and L1 ipsilateral to the injury site were harvested 14 days after the surgery and examined by electron microscopy. (A) A cell in the anterior horn shows accumulation of several high electron-dense organelles in the perinuclear region. These organelles appear homogeneous and are termed ''type I organelles'' (arrow). (B) Another anterior horn cell shows perinuclear accumulation of high electron-dense organelles that contain membrane structures and are not homogeneous; they are termed ''type II organelles'' (arrows). Most of the cells with these organelles had either type I or type II accumulation, but not both. (C) Percentages of cells with more than 10 organelles of type I or II were counted in the spinal cords. There was a significant increase in cells with abnormal organelle accumulation in the injured cords (n = 5 mice) versus cords that received sham surgery (n = 5; p G 0.01. All data are reported as mean T SD. Independent samples t-test was performed). This increase affected spinal cords at both T10 and L1 levels. (D) In separate counts of type 2 organelles, there was a significant increase in the injured spinal cords versus the sham surgery controls (p G 0.05). The difference was found in both neurons and glia. (E) To verify the identity of the type 2 organelles, we performed immunoelectron microscopy with an antibody to the late endosomal marker LAMP2 that was labeled by secondary antibodies conjugated with gold particles and silver enhanced. LAMP2 is highly concentrated in type 2 organelles ([F] arrowheads); thus, they are late endosomes/lysosomes. colocalized with immunoreactivity for the neuronal marker neurofilament light chain (Figs. 3AYC) . Fig4 mRNA was also detectable in oligodendrocytes positive for adenomatous polyposis coli (Figs. 3DYF) but not in astrocytes that were labeled for GFAP (Figs. 3GYI) . Because there were a few cells wherein fig4 mRNA and GFAP seemed to overlap (Fig. 3J) , we imaged the z-axis of the spinal cord slices under high-power confocal microscopy. Stacking images showed that fig4 mRNA was not in astrocytes (Fig. 3K) . Together, these data suggest that cellular localization of fig4 transcripts was identical to those of Fig4 proteins in the CNS. Thus, transcription of fig4 is active in neurons and oligodendrocytes, but it is suppressed in astrocytes.
Fig4 Predominantly Resides in Early Endosomes
To determine the subcellular localization of Fig4, we performed immunocytochemistry on rat mixed DRG and cortical cultures. Because results were similar in these cultures, only data from the day 5 DRG culture are presented (Fig. 4) . After plating, the fixed cells appeared flat, thus permitting visualization of their subcellular structure under confocal microscopy. Cells were double stained with antibodies against Fig4 and an intracellular organelle marker, including calnexin for endoplasmic reticulum, gaintin for Golgi apparatus, EEA1 for early endosomes, and LAMP2a for late endosomes/lysosomes. Colocalization was verified using confocal imaging.
Fig4 immunoreactivity was diffuse in the DRG neuron cytoplasm, appearing as numerous ''dots.'' Golgi apparatuses labeled by gaintin were clustered in discrete small perinuclear areas and were clearly separated from Fig4 (Figs. 4CYC'' ). Immunoreactivity against markers of endoplasmic reticulum or late endosomes/lysosomes had a dotlike appearance as well but did not or only slightly overlapped with Fig4 immunoreactivity, respectively (Figs. 4BYB'' ). In contrast, many Fig4 dots overlapped with EEA1 immunoreactivity (Figs. 4AYA'' ), and to evaluate this issue further, we performed IEM with the Fig4 antibody. Fig4 was mainly seen in small vesicles with a diameter of 200 to 300 nm (Supplementary Fig. 2 ; http://links.lww.com/NEN/A291). Whereas we could not be certain that these vesicles were early endosomes by EM, their morphological features were not consistent with lysosomes. Together, these results suggest that Fig4 predominantly resides in early endosomes.
Fig4 Is Upregulated After Spinal Cord Transection Injury
Because Fig4 levels declined to a minimal level in the adult CNS, we questioned whether Fig4 would be upregulated after the nervous system is stressed, such as by trauma. There was a strong increase of Fig4 immunoreactivity at the injury sites, which persisted up to 2 months after the injury, the longest duration that we studied. Neurons were difficult to discern at the injury site and likely degenerated after the injury. A few cells survived with similar morphological features of neurons that were stained with Fig4 (Fig. 5) , suggesting that Fig4 was upregulated in these cells. Many Fig4-positive cells were colocalized with immunoreactivity for fibronectin (23) , suggesting that they were fibroblasts or inflammatory cells. Fig4 was not colocalized with GFAP, suggesting that Fig4 expression in the astrocytes remains suppressed in the injured area (Supplementary  Fig. 3 ; http://links.lww.com/NEN/A292).
In addition, we examined the noninjured site of the spinal cord at T10 and the caudal segment at L1. Immunoreactivity of Fig4 was detectable as numerous dots, which were morphologically consistent with neurites (Fig. 5) .
Lysosomes Accumulate in Spinal Neurons and Glia After the Injury
To verify Wallerian degeneration after hemitransection, the injured hemicords along with their noninjured hemicords at T10 were examined in mice using semithin sections and by EM. In addition, we examined the areas remote to the injury at L1. We focused on the dorsal horns of the L1 segment because their ascending axons were damaged during the hemitransection at T10. As expected, degenerated axons with collapsed myelin ovoids were clearly visible in the injured cords. In addition, many neurons or glia at bilateral T10 and L1 had numerous high electron-dense organelles accumulated in perinuclear regions. We classified these organelles into 2 types: type I organelles showed homogeneous electron density (Fig. 6A) , whereas type II organelles showed inhomogeneous darkness with membranelike structures within them (Fig. 6B) . Most of these cells had both type I and type II organelles, but each cell had a preponderance of either the type I organelles or the type II organelles. These organelles were seen in spinal cords with sham surgery, but there were usually less than 10 organelles per cell in the sham surgery cords and they were generally much smaller. We randomly imaged 525 cells in injured cords and 450 cells in sham surgery cords and counted percentages of cells positive for more than 10 electron-dense organelles. The proportion of these neurons in the injured spinal cords was 2 to 3 times higher than that in the sham surgery cords (Fig. 6C) . This difference was significant at both T10 and L1 levels (p G 0.01). When we counted neuronal and glial cells based on the type II organelle accumulation, similar differences were also found between the injured and sham surgery cords (p G 0.05; Fig. 6D ).
Based on their morphological features, the type II organelles appeared similar to those that we found in spinal motor neurons and glia of plt mice that do not express Fig4; in plt mice, they were predominantly lysosomes (9) . To verify the nature of the type II organelles in the present study, we performed IEM with an antibody against LAMP2; reactivity was revealed by gold particleYconjugated secondary antibody. The organelles had LAMP2 immunoreactivity (Fig. 6E) , consistent with the notion that the type II organelles are lysosomes. However, we cannot exclude the possibility that some of these organelles contain lipofuscin deposits. In contrast, type I organelles were rarely LAMP2 positive.
DISCUSSION
Our systematic analysis of Fig4 expression in the rodent nervous system suggests additional functions and possible pathogenetic involvement of Fig4. First, a robust expression of Fig4 in developing neurons suggests that it likely is required for normal neuron development. This is consistent with the occurrence of severe neuronal degeneration in Fig4-deficient mice. Second, Fig4 is particularly abundant in DRG sensory neurons throughout development, which parallels the finding of large numbers of vacuoles in fig4-null sensory neurons (4, 5) . We also observed a persistently high expression of Fig4 in myelinating Schwann cells, suggesting that it may be involved in both the development and maintenance of peripheral nervous system myelin. Indeed, we previously observed segmental demyelination and slowed conduction velocities in plt mice and patients with CMT4J; pain and pin-prick sensation were, however, preserved in the CMT4J patients (5) . It should also be noted that lack of Fig4 expression in astrocytes does not necessarily exclude involvement of astrocytes FIG4 deficiency.
We observed that Fig4 is often present in neuronal nuclei. Fig4 (also called SAC3 in mammalian cells) has been reported to be present in the cytoplasm and on the nuclear membrane, where it interacts with the protein complex of the nuclear membrane port. This interaction is thought to be important for the regulation of gene expression or DNA synthesis (24) . The prominent expression of Fig4 in the nuclei of immature neurons observed in the present study is consistent with this view.
Fig4 levels were found to be negligible in most cells of adult spinal cord other than oligodendrocytes. Inasmuch as Fig4 is hardly detectable in adult spinal motor neurons, it is not clear why loss of FIG4 is associated with an adult-onset motor neuron degeneration (5, 25) . However, motor neuron degeneration in amyotrophic lateral sclerosis is not a neuronal cellYautonomous process (26) , and our study demonstrated that spinal motor neurons are affected by abnormal lysosomal storage as early as P4. This pathological change was progressive during aging (9) and might lead to neuronal loss during adulthood. Furthermore, we show here that Fig4 is markedly upregulated in the spinal cord after injury (Fig. 5) . Because of the severe loss of neurons in the injured cord, most cells with the upregulated Fig4 would have to be nonneuronal (fibroblasts or inflammatory cells), although Fig4 in a few survived neurons might also be upregulated (Fig. 6B ). This upregulation is associated with excessive lysosomal storage in neurons/glia of the injured spinal cord. The accumulated lysosomes possess morphological features and molecular signatures similar to those in the fig4-null spinal cord (9) . Interestingly, lysosomal storage has also been found in animal models of motor neuron disease (27, 28) , Lewy body disease, and Alzheimer disease (29, 30) . Increased lysosomal storage in fig4-null neurons is particularly severe and takes place early; for instance, abnormal lysosomal storage in fig4-null neurons was detectable even at the age of P4 and affected more than 60% of neurons by the fifth week of the plt mouse life (9) . In contrast, hemitransection of wild-type spinal cord induced this accumulation in only 18% of adult neurons (Fig. 6D) . Thus, the absence of Fig4 appears to drastically accelerate the formation of lysosomal storage. Normal expression of Fig4/ PI3,5P 2 may, therefore, be required to prevent neurons and glia from excessive lysosomal accumulation. Indeed, knockout of A-hexosaminidase in mice results in abnormal lysosomal storage and neuronal degeneration, including loss of spinal motor neurons. Removal of glycosphingolipid accumulation in the lysosomes reverses the neuronal degeneration, which suggests a pathogenetic role for lysosomal storage in the neuronal degeneration (31) . Therefore, it is reasonable to speculate that abnormal lysosomal storage in spinal motor neurons in Fig4 deficiency may predispose the affected neurons to degeneration. Additional intrinsic or extrinsic factors, such as secondary genetic modifier or trauma, may have to participate to cause the early or late onset in patients with FIG4 deficiency (6) , but how the upregulated Fig4 in the nonneuronal cells (either fibroblasts or inflammatory cells) affects lysosomal accumulation in the injured spinal cord is still unclear. A partial contribution of lipofuscin deposits in the accumulated lysosomes also cannot be excluded. Together, the present novel findings not only extend the functional significance of Fig4 but also suggest that Fig4/PI3,5P 2 signaling may play roles in regulating the lysosomal accumulation in other neurodegenerative disorders.
Our finding also provides an interesting contrast to what has been observed in CMT4B1/2 that is caused by recessive mutations in MTMR2 or MTMR13, respectively. Both MTMR2 and MTMR13 are phosphatases with specificity toward the 5-head phosphate on the inositol ring of PI3,5P 2 . Loss of function of MTMR2/13 increases PI3,5P 2 and causes dysmyelination (32) . Together, these diseases indicate that PI3,5P 2 in myelinating glia has to be fine tuned at a proper range to maintain normal myelination. This fine tuning depends on activities of a variety of enzymes, including Fig4 and MTMR2/13.
Finally, our confocal imaging data show that Fig4 predominantly resides in early endosomes, whereas vacuoles in fig4-deficient cells were mainly found in late endosomes/lysosomes (5, 9) . This is not surprising. First, PIKfyve, the main interacting partner of Fig4, is localized in early endosomes (33) . Second, PIKfyve/Fig4 protein complex has to be recruited onto early endosomes to synthesize PI3,5P 2 before the endosomes are evolved into late endosomes/lysosomes where PI3,5P 2 is highly demanded. When the absence of Fig4 depletes PI3,5P 2 , vacuoles are expected to take place in the late endosomes/ lysosomes (4, 34, 35) .
In summary, our study has systematically localized Fig4 in the developing and mature nervous system. We observed robust expression of Fig4 in developing neural tissues that was markedly decreased in the adult CNS. These findings are well in line with severe neuronal degeneration observed in patients and mice with Fig4 deficiency. Moreover, our finding that Fig4 is upregulated after spinal cord injury suggests that it may play a role in neural repair.
